Xiubao Ren

发表

Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients

Ying Chen, Lei Zhang, Q. Hao, 2013, Cancer Cell International.

A phase I study of FCN-411, a pan-HER inhibitor, in EGFR-mutated advanced NSCLC after progression on EGFR tyrosine kinase inhibitors.

Cheng-ling Zhao, H. Pan, Jiangtao Sun, 2022, Lung cancer.

Single-cell Pro ling of Immune cells After Neoadjuvant Pembrolizumab and Chemotherapy in A non-small cell lung cancer (NSCLC)

F. Wei, Wenwen Yu, Jian You, 2021 .

Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence.

L. Liu, Yu Zhao, F. Wei, 2022, Experimental cell research.

m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment

Xianhuo Wang, B. Meng, Xiubao Ren, 2022, Frontiers in Immunology.

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma

Q. Zhai, Xianhuo Wang, B. Meng, 2022, Frontiers in Immunology.

A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.

Q. Zhai, Xianhuo Wang, B. Meng, 2022, Clinical immunology.

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma

Xianhuo Wang, B. Meng, Xiubao Ren, 2022, Clinical and translational medicine.

Self-adaptive virtual microchannel for continuous enrichment and separation of nanoparticles

W. Pang, X. Duan, Xuejiao Chen, 2022, Science advances.

Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

F. Wei, Wenwen Yu, Xiubao Ren, 2022, Cell Death & Disease.

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

Xianhuo Wang, B. Meng, Xiubao Ren, 2022, Frontiers in Oncology.

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keyst

L. Liu, B. Meng, Xiubao Ren, 2022, Annals of translational medicine.

Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Xianhuo Wang, B. Meng, Xiubao Ren, 2022, BioMed research international.

Manipulation of single cells via a Stereo Acoustic Streaming Tunnel (SteAST)

Chongling Sun, W. Pang, X. Duan, 2022, Microsystems & nanoengineering.

A novel clinical immune‐related prognostic model predicts the overall survival of mantle cell lymphoma

Q. Cai, Yi Wang, Q. Zhai, 2022, Hematological oncology.

Significance of the Absolute Number and Ratio of Metastatic Lymph Nodes in Predicting Postoperative Survival for the International Federation of Gynecology and Obstetrics Stage IA2 to IIA Cervical Cancer

Ying Chen, Q. Hao, Jing Tian, 2013, International Journal of Gynecologic Cancer.

Dysregulated Th1 cells in lung squamous cell carcinoma

Peng Zhang, Xiubao Ren, Cihui Yan, 2022, Journal of Leukocyte Biology.

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Tao Zhang, Wei Shi, Jian-hua Chang, 2022, Cancer communications.

Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma

Hao Wang, Xiubao Ren, Yu Zhao, 2022, Frontiers in Immunology.

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD3+CD56+ NKT-Like Cells

Siyu Zhu, Yang Wang, F. Wei, 2022, Journal of oncology.

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer

Xiubao Ren, Lin Zhao, Ningning Li, 2019, Translational oncology.

Oncogenic Mutations Regulate Tumor Microenvironment through Induction of Growth Factors and Angiogenic Mediators

C. Arteaga, L. Debusk, P. Lin, 2010, Oncogene.

Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer

L. Liu, F. Wei, Wenwen Yu, 2022, Cancer Gene Therapy.

Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer.

Xiubao Ren, S. Cao, Li Zhou, 2023, Bulletin du cancer.

The Distinct Impact of TAM Infiltration on the Prognosis of Patients With Cardia and Non-Cardia Gastric Cancer and Its Association With H. pylori Infection

Xiubao Ren, Li Zhang, Qian Sun, 2021, Frontiers in Oncology.

LYMPHOID NEOPLASIA A clinically relevant in vivo zebra ﬁ sh model of human multiple myeloma to study preclinical therapeutic ef ﬁ cacy

Jian-jun Zhao, N. Munshi, Y. Tai, 2016 .

Dysregulated Th1 cells in lung squamous cell carcinoma

Peng Zhang, Xiubao Ren, Cihui Yan, 2022, Journal of leukocyte biology.

Novel strategies for cancer immunotherapy: counter-immunoediting therapy

Xiubao Ren, Qian Sun, Shaochuan Liu, 2023, Journal of Hematology & Oncology.

DC101, an anti-VEGFR2 agent, promotes high-endothelial venule formation and immune infiltration versus SAR131675 and fruquintinib.

Hua Zhao, Jian Zhou, Wenwen Yu, 2023, Biochemical and biophysical research communications.

Abemaciclib抑制c-Myc高表达小细胞肺癌增殖、侵袭和迁移的生物学功能的研究

Lei-na Sun, Ying Han, Wenwen Yu, 2023, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)

P. Zhang, L. Liu, B. Meng, 2022, Frontiers in Oncology.

Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients

Ying Chen, Lei Zhang, Q. Hao, 2013, Cancer Cell International.

Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer

Xiubao Ren, Peiyan Zhao, Ying Cheng, 2023, Thoracic cancer.

OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.

K. Fu, Chengfeng Bi, Xianhuo Wang, 2023, Clinical immunology.

ADAM10 mediates the cell invasion and metastasis of human esophageal squamous cell carcinoma via regulation of E-cadherin activity.

X. Bai, Xiubao Ren, Lei Zhang, 2016, Oncology reports.

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells

F. Wei, Wenwen Yu, Xiubao Ren, 2023, NPJ precision oncology.

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Wenfeng Li, Baocheng Wang, J. Wang, 2023, Therapeutic advances in medical oncology.

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma

Z. Chavoshzadeh, Xianhuo Wang, B. Meng, 2023, British journal of haematology.

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

J. Locasale, D. Pizzo, Xiwei Wu, 2018, Nature Cell Biology.

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.

Z. Chavoshzadeh, Xianhuo Wang, B. Meng, 2023, British Journal of Haematology.

The prognostic value of a 4‐factor neoimmunologic score system in non‐small cell lung cancer

F. Wei, Xiubao Ren, Yuan Li, 2022, Journal of leukocyte biology.

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Guihua Sun, Jinhui Wang, Yate-Ching Yuan, 2012, Journal of Translational Medicine.

P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLC

X. Jiang, J. Fang, F. Wu, 2021 .

OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

X. Jiang, J. Fang, C. Zhu, 2019, Journal of Thoracic Oncology.

Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer

Hua Zhao, Wenwen Yu, Xiubao Ren, 2023, Technology in cancer research & treatment.

Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence.

L. Liu, Yu Zhao, F. Wei, 2022, Experimental cell research.

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Guihua Sun, Jinhui Wang, Yate-Ching Yuan, 2012, Journal of Translational Medicine.